Something extraordinary occurred on Tuesday—Bright Minds Biosciences (DRUG) surged by an astonishing 1,000%, with a staggering 3,000% gain over the last five days. Incredible,...
Bright Minds Biosciences Inc. (NASDAQ: DRUG) is a biotechnology company focused on developing novel therapies for neurological and neuropsychiatric disorders. One such therapy involves healing the...
Bright Minds Biosciences has announced the commencement of its Phase 2 clinical trial for BMB-101.
On September 25th, the company will host an event to...
RenovoRx's TAMP™ technology delivers chemotherapy directly to tumors, reducing side effects and improving treatment efficacy.
With a projected 330% price increase, RenovoRx is gaining investor...